-
(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9H-purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide dihydrochloride
-
ChemBase ID:
154171
-
Molecular Formular:
C22H31Cl2N7O5
-
Molecular Mass:
544.43144
-
Monoisotopic Mass:
543.17637249
-
SMILES and InChIs
SMILES:
CN(C)c1c2c(ncn1)n(cn2)[C@H]1[C@@H]([C@@H]([C@H](O1)CO)NC(=O)[C@H](Cc1ccc(cc1)OC)N)O.Cl.Cl
Canonical SMILES:
OC[C@H]1O[C@H]([C@@H]([C@@H]1NC(=O)[C@H](Cc1ccc(cc1)OC)N)O)n1cnc2c1ncnc2N(C)C.Cl.Cl
InChI:
InChI=1S/C22H29N7O5.2ClH/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12;;/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32);2*1H/t14-,15+,16+,18+,22+;;/m0../s1
InChIKey:
MKSVFGKWZLUTTO-FZFAUISWSA-N
-
Cite this record
CBID:154171 http://www.chembase.cn/molecule-154171.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9H-purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide dihydrochloride
|
|
|
IUPAC Traditional name
|
puromycin dihydrochloride
|
|
|
Synonyms
|
Puromycin dihydrochloride
|
3′-[α-Amino-p-methoxyhydrocinnamamido]-3′-deoxy-N,N-dimethyladenosine dihydrochloride
|
Puromycin dihydrochloride from Streptomyces alboniger
|
Puromycin
|
3′-[α-Amino-p-methoxyhydrocinnamamido]-3′-deoxy-N,N-dimethyladenosine 二盐酸盐
|
Puromycin dihydrochloride 二盐酸盐 来源于白色链球菌
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.349177
|
H Acceptors
|
10
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-2.7910688
|
LogD (pH = 7.4)
|
-1.0220252
|
Log P
|
-0.29873976
|
Molar Refractivity
|
122.9609 cm3
|
Polarizability
|
47.873817 Å3
|
Polar Surface Area
|
160.88 Å2
|
Rotatable Bonds
|
8
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P9620
|
Application Puromycin is an aminonucleoside antibiotic that is derived from Streptomyces alboniger. It allows selection for cells that contain the resistance gene puromycin N-acetyl-transferase (PAC). It has been used to study vascular smooth muscle cell viability after treatment in the rabbit model 1. Puromycin is used to produce enhanced green fluorescent protein (EGFP) transgenic piglets after somatic cell cloning and embryo transfer2. Biochem/physiol Actions Puromycin inhibits bacterial and mammalian protein synthesis by causing premature chain termination during translation taking place in the ribosome. Puromycin is a reversible inhibitor of dipeptidyl-peptidase II (serine peptidase) and cytosol alanyl aminopeptidase. Suitability Tested on HeLa cells for cell growth arrest and selection of cells after transfection of the pac resistance gene. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
P7255
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Application Recommended for use as a selection agent at a range of 1-10 μg/mL. Packaging 1 g in glass bottle 25, 100, 250, 500 mg in glass bottle Biochem/physiol Actions Nucleoside antibiotic. Protein synthesis inhibitor that causes premature chain termination by acting as an analog of the 3′-terminal end of aminoacyl-tRNA. Prevents growth of bacteria, protozoa, algae, and mammalian cells. Acts very quickly and can kill 99% of cells within 2 days, the resistance gene (puromycin acetyltransferase) gives very effective protection. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
P8833
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Application May be used in vitro as a selection agent for cells transfected with puromycin N-acetyl transferase gene (pac). Biochem/physiol Actions Nucleoside antibiotic. Protein synthesis inhibitor that causes premature chain termination by acting as an analog of the 3′-terminal end of aminoacyl-tRNA. Prevents growth of bacteria, protozoa, algae, and mammalian cells. Acts very quickly and can kill 99% of cells within 2 days, the resistance gene (puromycin acetyltransferase) gives very effective protection. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
82595
|
Other Notes Causes premature chain termination in protein synthesis by acting as an analog of aminoacyl-tRNA.; Inhibitor of aminopeptidase and enkephalinase. Photoincorporation of puromycin into rat liver ribosomes1; Immunosuppressive effect2 Biochem/physiol Actions Nucleoside antibiotic. Protein synthesis inhibitor that causes premature chain termination by acting as an analog of the 3′-terminal end of aminoacyl-tRNA. Prevents growth of bacteria, protozoa, algae, and mammalian cells. Acts very quickly and can kill 99% of cells within 2 days, the resistance gene (puromycin acetyltransferase) gives very effective protection. |
PATENTS
PATENTS
PubChem Patent
Google Patent